Pediatr. pro Praxi, 2001; 3: 120-123

Nefrotický syndrom

MUDr. Pavel Geier
Dětská klinika LF UP a FN Olomouc

Keywords: nephrotic syndrome, corticoids, cyclosporine A, levamisole, cyclophosphamide.

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geier P. Nefrotický syndrom. Pediatr. praxi. 2001;2(3):120-123.

Článek se zabývá diagnostikou a léčbou nefrotického syndromu u dětí. Důraz je kladen na léčebné protokoly, které vycházejí z mezinárodních multicentrických studií.

Nephrotic syndrome

The article deals in diagnosis and treatment of nephrotic syndrome in children. There are accented treatment protocols outgoing from multicentric studies.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Clark A.G., Barrat M.T.: Steroid-Responsive Nephrotic Syndrome. In Barrat M.T., Avner E.D., Harmon W.: Pediatric Nephrology, 4th ed. Baltimore, Lippincott Williams and Wilkins, 1999. Str. 731-747.
    2. Janda J.: Nefrotický syndrom u dětí. Čs Pediat., 1992, 47: 513 519.
    3. Brodehl J.: The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur. J. Pediatr., 1991, 150: 380-387. Go to original source... Go to PubMed...
    4. Bargman J.M.: Management of minimal lesion glomerulonephritis: Evidence - based recommendations. Kidney Int, 1999, 55: suppl 70: S3 - S16. Go to original source... Go to PubMed...
    5. Durkan A.M., Hodson E.M., Willis N.S., Craig J.C.: Immunosupresive agents in childhood nephrotic syndrome: A meta - analysis of randomized control trials. Kidney Int 2001, 59: 1919-27. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.